DOCSLIB.ORG

Table of Contents 1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Table of Contents 1 GENERAL THORACIC SURGERY DATABASE v.2.3 TRAINING MANUAL September 2017 Table of Contents 1. Demographics ................................................................................................................................................................. 2 2. Follow Up ........................................................................................................................................................................ 9 3. Admission ..................................................................................................................................................................... 10 4. Pre-Operative Evaluation ............................................................................................................................................. 14 5. Diagnosis (Category of Disease) ................................................................................................................................... 48 6. Procedure ..................................................................................................................................................................... 70 7. Post-Operative Events ................................................................................................................................................ 111 8. Discharge .................................................................................................................................................................... 136 9. Quality Measures ....................................................................................................................................................... 140 10. Nodal Stations ........................................................................................................................................................ 143 9/2017 1 GENERAL THORACIC SURGERY DATABASE v.2.3 TRAINING MANUAL September 2017 The training manual is intended to clarify data definitions, provide examples and answer FAQs. It will be updated with new FAQs. 1. Demographics Seq. #: 10 Long Name: Operations Table Record Identifier Short Name: RecordID Definition: An arbitrary, unique value generated by the software that permanently identifies each record in the participant's database (note that unlike the PatID value, this does not identify the individual patient). The value of the identifier is a combination of a code assigned to the software developer by the STS, and a value generated by the software to create a unique value. Once assigned to a record, this value can never be changed or reused. The data warehouse will use this value to communicate issues about individual records with the participant. It may also be used by the data warehouse to link this record to other clinical data. Intent/Clarification: A record should be initiated for inpatient and outpatient thoracic procedures on every visit to the operating room (includes the Endoscopy Suite or Outpatient Surgical Center) whether planned or unplanned. Seq. #: 20 Long Name: Procedures Table Record Identifier Short Name: RecordID Definition: This field is the foreign key that links this record with the associated records in the "Operations" table. Seq. #: 30 Long Name: Software Vendor's Identification Short Name: VendorID Definition: Software vendor's identification assigned by the STS. Seq. #: 40 Long Name: Vendor's Software Version Number Short Name: SoftVrsn Definition: Vendor's software product version number identifying the software which created this record. Vendor controls the value in this field. Version passing certification/harvest testing will be noted at the data warehouse. Seq. #: 50 Long Name: Version Of STS Data Specification Short Name: DataVrsn Definition: Version number of the STS Data Specifications/Dictionary, to which the record conforms. The value will identify which fields should have data, and what are the valid data values for those fields. It must be the version implemented in the software at the time the record was created. The value must be entered into the record automatically by the software. Seq. #: 60 Long Name: Participant ID Short Name: ParticID 9/2017 2 GENERAL THORACIC SURGERY DATABASE v.2.3 TRAINING MANUAL September 2017 Definition: Participant ID is a unique number assigned to each database participant by the STS. A database participant is defined as one entity that signs a Participation Agreement with the STS, submits one data file to the harvest, and gets back one report on their data. The participant ID must be entered into each record. Intent/Clarification: Each participant's data, if submitted to harvest, must be in one data file. If one participant keeps data in more than one file (e.g. at two sites), the participant must combine them back into one file for harvest submission. If two or more participants share single purchased software and enter cases into one database, the data must be extracted into two different files, one for each participant ID, with each record having the correct participant ID number. Seq. #: 70 Long Name: Operations Table Patient Identifier Short Name: PatID Definition: The foreign key that links this record with the associated records in the "Demographics" table. Intent/Clarification: Once assigned to a patient, this number can never be changed or reused. Seq. #: 80 Long Name: Demographics Table Patient Identifier Short Name: PatID Definition: An arbitrary value that uniquely and permanently identifies each patient. The value of the identifier is a combination of a code assigned to the software developer by the STS, and a value generated by the software to create a unique value. The value in this field cannot be a value that would identify the patient outside of the database (such as Medical Record Number or Social Security Number). Once a value has been assigned to a patient, it can never be changed or reused. This field is the primary key that links this record with the associated records in the "Operations" table. Seq. #: 90 Long Name: Demographics Table Data Version Short Name: DemogDataVrsn Definition: Version number of the STS Data Specifications/Dictionary, to which the Demographics record conforms. The value will identify which fields should have data, and what are the valid data for those fields. It must be the version implemented in the software at the time the record was created. The value must be entered into the record automatically by the software. Note that the data version of the demographics record does not necessarily need to match the data version of all of the associated operation records for that patient. This is because new data versions might be implemented in the software and used for the creation of operation records after a demographics record has been created for a patient. Seq. #: 100 Long Name: Medical Record # Short Name: MedRecN Definition: Indicate the patient's medical record number at the hospital where surgery occurred. This field should be collected in compliance with state/local privacy laws. Intent/Clarification: This field is not required for record inclusion 9/2017 3 GENERAL THORACIC SURGERY DATABASE v.2.3 TRAINING MANUAL September 2017 Seq. #: 110 Long Name: Patient's First Name Short Name: PatFName Definition: Indicate the patient's medical record number at the hospital where surgery occurred. This field should be collected in compliance with state/local privacy laws. Intent/Clarification: This field is not required for record inclusion Seq. #: 121 Long Name: Patient's Middle Name Short Name: PatMName Definition: Indicate the patient's middle name as documented in the medical record. Leave "blank" if no middle name. This field should be collected in compliance with state/local privacy laws. Intent/Clarification: Leave “blank” if no middle initial. This field is not required for record inclusion Seq. #: 130 Long Name: Patient's Last Name Short Name: PatLName Definition: Indicate the patient's medical record number at the hospital where surgery occurred. This field should be collected in compliance with state/local privacy laws. Intent/Clarification: This field is not required for record inclusion Seq. #: 140 Long Name: Social Security Number Short Name: SSN Definition: Indicate the patient’s Social Security Number (SSN). Although this is the Social Security Number in the USA, other countries may have a different National Patient Identifier Number. For example in Canada, this would be the Social Insurance Number. This field should be collected in compliance with state/local privacy laws. Intent/Clarification: This field is not required for record inclusion Seq. #: 151 Long Name: Patient Participating In STS-Related Clinical Trial Short Name: ClinTrial Definition: Indicate which, if any, STS-related clinical trial in which the patient is participating. The STS will assign a code to each clinical trial as they begin collecting data. 9/2017 4 GENERAL THORACIC SURGERY DATABASE v.2.3 TRAINING MANUAL September 2017 Intent/Clarification: This applies only to STS trials. The instructions will be posted here when trials are available. There are currently no trials underway. Seq. #: 152 Long Name: Patient Participating In STS-Related Clinical Trial - Patient ID Short Name: ClinTrialPatID Definition: Indicate the patient identifier used to identify the patient in the clinical trial. Seq. #: 160 Long Name: Date Of Birth Short Name: DOB Definition: Indicate the patient's date of birth using 4-digit format for year. This field should be collected in compliance with state/local privacy
Load more

Recommended publications
  • Follicular Lymphoma
    Follicular Lymphoma What is follicular lymphoma? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines FOLLICULAR LYMPHOMA: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by the Anticancer Fund as a service to patients, to help patients and their relatives better understand the nature of follicular lymphoma and appreciate the best treatment choices available according to the subtype of follicular lymphoma. We recommend that patients ask their doctors about what tests or types of treatments are needed for their type and stage of disease. The medical information described in this document is based on the clinical practice guidelines of the European Society for Medical Oncology (ESMO) for the management of newly diagnosed and relapsed follicular lymphoma. This guide for patients has been produced in collaboration with ESMO and is disseminated with the permission of ESMO. It has been written by a medical doctor and reviewed by two oncologists from ESMO including the lead author of the clinical practice guidelines for professionals, as well as two oncology nurses from the European Oncology Nursing Society (EONS). It has also been reviewed by patient representatives from ESMO’s Cancer Patient Working Group. More information about the Anticancer Fund: www.anticancerfund.org More information about the European Society for Medical Oncology: www.esmo.org For words marked with an asterisk, a definition is provided at the end of the document. Follicular Lymphoma: a guide for patients - Information based on ESMO Clinical Practice Guidelines – v.2014.1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO.
    [Show full text]
  • Nonintubated Thoracoscopic Surgery Using Regional Anesthesia and Vagal Block and Targeted Sedation
    Original Article Nonintubated thoracoscopic surgery using regional anesthesia and vagal block and targeted sedation Ke-Cheng Chen1,2, Ya-Jung Cheng3, Ming-Hui Hung3, Yu-Ding Tseng1, Jin-Shing Chen1,2 1Department of Surgery, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin County, Taiwan; 2Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; 3Department of Anesthesiology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan Corresponding to: Dr. Jin-Shing Chen. Department of Surgery, National Taiwan University Hospital, No. 7, Chung Shan South Road, Taipei, Taiwan. Email: [email protected]. Objective: Thoracoscopic surgery without endotracheal intubation is a novel technique for diagnosis and treatment of thoracic diseases. This study reported the experience of nonintubated thoracoscopic surgery in a tertiary medical center in Taiwan. Methods: From August 2009 through August 2013, 446 consecutive patients with lung or pleural diseases were treated by nonintubated thoracoscopic surgery. Regional anesthesia was achieved by thoracic epidural anesthesia or internal intercostal blockade. Targeted sedation was performed with propofol infusion to achieve a bispectral index value between 40 and 60. The demographic data and clinical outcomes were evaluated by retrospective chart review. Results: Thoracic epidural anesthesia was used in 290 patients (65.0%) while internal intercostal blockade was used in 156 patients (35.0%). The final diagnosis were primary lung cancer in 263 patients (59.0%), metastatic lung cancer in 38 (8.5%), benign lung tumor in 140 (31.4%), and pneumothorax in 5 (1.1%). The median anesthetic induction time was 30 minutes by thoracic epidural anesthesia and was 10 minutes by internal intercostal blockade.
    [Show full text]
  • Your Lung Operation Booklet
    1 AMERICAN COLLEGE OF SURGEONS DIVISION OF EDUCATION SURGICAL PATIENT EDUCATION Table of Contents Welcome ...................................................................................1 Your Lungs ...............................................................................2 Lung Cancer ...........................................................................3 SURGICAL Understanding Your Operation ........................................4 PATIENT Preoperative Tests ................................................................5 EDUCATION Home Preparation ................................................................8 The Day of Your Operation ...............................................13 After Your Operation ..........................................................14 Your Recovery and Discharge .........................................17 When to Call Your Doctor .................................................19 Welcome You and your family are important members of the surgical team. The American College of Surgeons (ACS) “Your Lung Operation: Education for a Better Recovery” program will help you prepare for your operation and recovery. You and your family will know what to expect. You will learn how to work with your surgical team to ensure that you have the best surgical outcomes. COMPLETE THE “YOUR LUNG OPERATION” EDUCATION PROGRAM: Watch the DVD Read the booklet Review the Medication List and Quit Smoking Resources (inside front cover) Complete the Activity Log (inside front cover) Send us your evaluation after
    [Show full text]
  • December 2020 E-Tips Solid Tumor Rules
    New Jersey State Cancer Registry December 2020 E-Tips Cancer Epidemiology Services http://www.nj.gov/health/ces (609) 633-0500 Solid Tumor Rules: December 2020 Update ICD-0-3.2 changes have also been added to applicable site modules. Most changes are minor: terminology, additional definitions, new notes and examples. In order to clarify histology coding instructions, new rules have been added and histology tables updated. These updates do not require review of already abstracted cases. The December 2020 rules replace the current rules and should be used now. SEER Strongly recommends reading the December 2020 Change Log to understand what changes were made. The updated Solid Tumor Rules may be accessed at: https://seer.cancer.gov/tools/solidtumor/ Reportability Changes for 2021 Radiation Coding Total Dose (1533) Starting 01/01/2021 the following terms are reportable: If doses across phases to a single point of region, code Sum of all phases. ** (see 2019 update below) Early or evolving melanoma in situ, or any other early or If doses are to multiple metastatic sites, code highest evolving melanoma, are reportable. dose site. If doses are to primary site and metastatic site, code dose All GIST tumors are reportable and classified as 8936/3 in from the primary site only. ICD-O-3.2. When you have two different sites, you cannot add the Nearly all thymomas are reportable; the exceptions are doses together to get the total dose. microscopic thymoma or thymoma benign (8580/0), micronodular thymoma with lymphoid stroma (8580/1), Radiation Tips and updates for 2019 and ectopic hamartomatous thymoma (8587/0).
    [Show full text]
  • About Mastectomy and Sentinel Lymph Node Biopsy
    All About Mastectomy and Sentinel Lymph Node Biopsy One of the most important goals of Moffitt Cancer Center is to provide you with quality patient care through education, research and patient care. The following information has been developed to help you understand the mastectomy and sentinel lymph node biopsy procedures for which you have been scheduled. Members of your health care team will review this information with you and answer any questions that you may have. Definitions: Mastectomy – Removal of the entire breast but not the muscles underneath. Lymph Nodes - Small bean shaped glands found in the armpit. They remove waste and fluids from the arm and breast and help fight infection. They are also call lymph glands. Sentinel Lymph Node - The first place breast cancer may metastasize (or spread) is to lymph nodes in the axilla (underarm area) on the side of the body where the cancer is. The first lymph node(s) are referred to as the sentinel lymph node(s) or the “gate keepers”. These nodes are first biopsied to determine if the cancer has spread. If cancer cells are not found in the sentinel lymph node(s) that were removed, it will not be necessary to remove the remaining lymph nodes in the arm pit. Sentinel Lymph Node Mapping and Biopsy - This procedure is a two step process. Performing the sentinel lymph node biopsy requires a small incision in your axilla. In the first step, the doctor injects a radioactive substance and/ or blue dye in the area around the tumor. Lymphatic channels (like blood vessels) carry these materials to the sentinel lymph node.
    [Show full text]
  • Answer Key Chapter 1
    Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 1 of 101 Answer Key Chapter 1 Introduction to Clinical Coding 1.1: Self-Assessment Exercise 1. The patient is seen as an outpatient for a bilateral mammogram. CPT Code: 77055-50 Note that the description for code 77055 is for a unilateral (one side) mammogram. 77056 is the correct code for a bilateral mammogram. Use of modifier -50 for bilateral is not appropriate when CPT code descriptions differentiate between unilateral and bilateral. 2. Physician performs a closed manipulation of a medial malleolus fracture—left ankle. CPT Code: 27766-LT The code represents an open treatment of the fracture, but the physician performed a closed manipulation. Correct code: 27762-LT 3. Surgeon performs a cystourethroscopy with dilation of a urethral stricture. CPT Code: 52341 The documentation states that it was a urethral stricture, but the CPT code identifies treatment of ureteral stricture. Correct code: 52281 4. The operative report states that the physician performed Strabismus surgery, requiring resection of the medial rectus muscle. CPT Code: 67314 The CPT code selection is for resection of one vertical muscle, but the medial rectus muscle is horizontal. Correct code: 67311 5. The chiropractor documents that he performed osteopathic manipulation on the neck and back (lumbar/thoracic). CPT Code: 98925 Note in the paragraph before code 98925, the body regions are identified. The neck would be the cervical region; the thoracic and lumbar regions are identified separately. Therefore, three body regions are identified. Correct code: 98926 Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 2 of 101 6.
    [Show full text]
  • Consensus Guideline on the Management of the Axilla in Patients with Invasive/In-Situ Breast Cancer
    - Official Statement - Consensus Guideline on the Management of the Axilla in Patients With Invasive/In-Situ Breast Cancer Purpose To outline the management of the axilla for patients with invasive and in-situ breast cancer. Associated ASBrS Guidelines or Quality Measures 1. Performance and Practice Guidelines for Sentinel Lymph Node Biopsy in Breast Cancer Patients – Revised November 25, 2014 2. Performance and Practice Guidelines for Axillary Lymph Node Dissection in Breast Cancer Patients – Approved November 25, 2014 3. Quality Measure: Sentinel Lymph Node Biopsy for Invasive Breast Cancer – Approved November 4, 2010 4. Prior Position Statement: Management of the Axilla in Patients With Invasive Breast Cancer – Approved August 31, 2011 Methods A literature review inclusive of recent randomized controlled trials evaluating the use of sentinel lymph node surgery and axillary lymph node dissection for invasive and in-situ breast cancer as well as the pathologic review of sentinel lymph nodes and indications for axillary radiation was performed. This is not a complete systematic review but rather, a comprehensive review of recent relevant literature. A focused review of non-randomized controlled trials was then performed to develop consensus guidance on management of the axilla in scenarios where randomized controlled trials data is lacking. The ASBrS Research Committee developed a consensus document, which was reviewed and approved by the ASBrS Board of Directors. Summary of Data Reviewed Recommendations Based on Randomized Controlled
    [Show full text]
  • Endoscopy Matrix
    Endoscopy Matrix CPT Description of Endoscopy Diagnostic Therapeutic Code (Surgical) 31231 Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) X 31233 Nasal/sinus endoscopy, diagnostic with maxillary sinusoscopy (via X inferior meatus or canine fossa puncture) 31235 Nasal/sinus endoscopy, diagnostic with sphenoid sinusoscopy (via X puncture of sphenoidal face or cannulation of ostium) 31237 Nasal/sinus endoscopy, surgical; with biopsy, polypectomy or X debridement (separate procedure) 31238 Nasal/sinus endoscopy, surgical; with control of hemorrhage X 31239 Nasal/sinus endoscopy, surgical; with dacryocystorhinostomy X 31240 Nasal/sinus endoscopy, surgical; with concha bullosa resection X 31241 Nasal/sinus endoscopy, surgical; with ligation of sphenopalatine artery X 31253 Nasal/sinus endoscopy, surgical; with ethmoidectomy, total (anterior X and posterior), including frontal sinus exploration, with removal of tissue from frontal sinus, when performed 31254 Nasal/sinus endoscopy, surgical; with ethmoidectomy, partial (anterior) X 31255 Nasal/sinus endoscopy, surgical; with ethmoidectomy, total (anterior X and posterior 31256 Nasal/sinus endoscopy, surgical; with maxillary antrostomy X 31257 Nasal/sinus endoscopy, surgical; with ethmoidectomy, total (anterior X and posterior), including sphenoidotomy 31259 Nasal/sinus endoscopy, surgical; with ethmoidectomy, total (anterior X and posterior), including sphenoidotomy, with removal of tissue from the sphenoid sinus 31267 Nasal/sinus endoscopy, surgical; with removal of
    [Show full text]
  • Application of Preoperative Computed Tomographic Lymphography For
    Wen et al. BMC Surg (2021) 21:187 https://doi.org/10.1186/s12893-021-01190-7 RESEARCH ARTICLE Open Access Application of preoperative computed tomographic lymphography for precise sentinel lymph node biopsy in breast cancer patients Shishuai Wen1,2,3†, Yiran Liang1†, Xiaoli Kong1, Baofeng Liu4, Tingting Ma1, Yeqing Zhou1, Liyu Jiang1, Xiaoyan Li1 and Qifeng Yang1,5,6* Abstract Background: In light of the extensive application of sentinel lymph node biopsy (SLNB) in clinically node-negative breast cancer patients and the recently investigated failure of SLNB after lumpectomy, it has become important to explore methods for preoperative mapping of sentinel lymph nodes (SLNs) and their lymphatics to direct precise SLNB and improve the identifcation rate of SLNs. Methods: Twenty-seven patients with suspected breast cancer based on the results of the clinical examination and imaging were enrolled in the study. Computed tomographic lymphography (CTLG) followed by CT three-dimensional reconstruction was performed to determine the localization of SLNs and lymphatics on the body surface preopera- tively. Intraoperatively combined staining with methylene blue and indocyanine green was used to evaluate the accuracy and feasibility of CTLG. Results: SLNs and lymphatics from the breast were identifed using CTLG in all patients, and preoperative SLNs and lymphatics localization on the body surface showed a signifcant role in the selection of operative incision and injec- tion points. The accuracy rate of SLN and lymphatic detection by CTLG was 92.6% compared with intraoperatively combined staining. Moreover, preoperative CTLG performed well in SLN number detection, and the accuracy rate was 95.2%. Conclusion: We evaluate the procedure and application of preoperative CTLG in the superfcial localization of SLNs and lymphatics, which may lead to a decreased incidence of cutting of the lymphatics of SLNs and consequently more rapid and accurate SLN detection.
    [Show full text]
  • Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
    Journal of Clinical Medicine Review Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma Ane Gerda Z Eriksson 1,2,* , Ben Davidson 2,3, Pernille Bjerre Trent 1,2, Brynhildur Eyjólfsdóttir 1, Gunn Fallås Dahl 1, Yun Wang 1 and Anne Cathrine Staff 2,4 1 Department of Gynecologic Oncology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway; [email protected] (P.B.T.); [email protected] (B.E.); [email protected] (G.F.D.); [email protected] (Y.W.) 2 Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, N-0316 Oslo, Norway; [email protected] (B.D.); [email protected] (A.C.S.) 3 Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway 4 Division of Obstetrics and Gynaecology, Oslo University Hospital, Ullevål, N-0424 Oslo, Norway * Correspondence: [email protected] Abstract: Sentinel lymph node (SLN) biopsy has emerged as an alternative staging approach in women with assumed early-stage endometrial carcinoma. Through image-guided surgery and pathologic ultrastaging, the SLN approach is introducing “precision medicine” to the surgical management of gynecologic cancers, providing a comprehensive evaluation of high-yield lymph nodes. This approach improves the surgeons’ ability to detect small-volume metastatic disease while reducing intraoperative and postoperative morbidity associated with lymphadenectomy. Although the majority of clinicians in Europe and the USA have recognized the value of SLN biopsy in endometrial carcinoma and introduced this as part of clinical practice, there is ongoing debate Citation: Eriksson, A.G.Z; Davidson, regarding its role in very low-risk patients as well as in patients at high risk of nodal metastasis.
    [Show full text]
  • Having a Sentinel Lymph Node Biopsy
    Having a sentinel lymph node biopsy The aim of this leaflet is to answer questions you may have about a sentinel lymph node (SLN) biopsy. The leaflet explains what the surgical procedure involves and the benefits and risks of having it. If you have any further questions or concerns, please feel free to speak to a member of your hospital team who would be happy to help. What is a sentinel lymph node biopsy? A biopsy is when a sample of tissue is taken and looked at under a microscope. An SLN biopsy is a surgical procedure to remove one or more of the nodes (glands) from under your arm (axilla) into which the lymph fluid from the breast first drains. These are then examined under a microscope to see if there are any breast cancer cells present. What is the lymphatic system? The lymphatic system is a system of channels in your body, which drains fluid from your body tissues. It plays an important part in keeping your blood clean and fighting infection. Breast cancer cells can spread through these channels. Lymph is a milky fluid and is rich in the white cells, which help us fight infections. It circulates around your body by passing through tiny, then larger vessels and lymph nodes (glands). Each area of the body will drain lymph fluid into certain nodes, usually to the group of nodes which is closest. In the breast this group is usually in the armpit. The first node the fluid drains in to is called the sentinel lymph node.
    [Show full text]
  • Standards for Oncology Registry Entry STORE 2018
    STandards for Oncology Registry Entry STORE 2018 Effective for Cases Diagnosed January 1, 2018 STORE STandards for Oncology Registry Entry Released 2018 (Incorporates all updates to Commission on Cancer, National Cancer Database Data standards since FORDS was revised in 2016) Effective for cases diagnosed January 1, 2018 See Appendix A for Updates since FORDS: Revised for 2016. Version 1.0 © 2018 AMERICAN COLLEGE OF SURGEONS All Rights Reserved STORE 2018 Table of Contents Table of Contents Table of Contents ......................................................................................................................... ii Foreword ..................................................................................................................................... 1 FROM “FORDS” TO “STORE” ..................................................................................................................... 1 Preface 2018 ................................................................................................................................ 2 Comorbidities and Complications ............................................................................................................. 2 Revisions to Staging Requirements ........................................................................................................... 2 Staging Data Items No Longer Required for Cases Diagnosed in 2018 and Later (Required for Cases Diagnosed 2017 and Earlier) ................................................................................................................
    [Show full text]